McDermott CJ - Search Results

1

Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS.

Miller TM, Cudkowicz ME, Genge A, Shaw PJ, Sobue G, Bucelli RC, Chiò A, Van Damme P, Ludolph AC, Glass JD, Andrews JA, Babu S, Benatar M, McDermott CJ, Cochrane T, Chary S, Chew S, Zhu H, Wu F, Nestorov I, Graham D, Sun P, McNeill M, Fanning L, Ferguson TA, Fradette S; VALOR and OLE Working Group. Miller TM, et al. Among authors: mcdermott cj. N Engl J Med. 2022 Sep 22;387(12):1099-1110. doi: 10.1056/NEJMoa2204705. N Engl J Med. 2022. PMID: 36129998 Free article. Clinical Trial.

2

Hereditary spastic paraplegia.

McDermott CJ, Shaw PJ. McDermott CJ, et al. Int Rev Neurobiol. 2002;53:191-204. doi: 10.1016/s0074-7742(02)53008-7. Int Rev Neurobiol. 2002. PMID: 12512341 Review. No abstract available.

3

Spastin and paraplegin gene analysis in selected cases of motor neurone disease (MND).

McDermott CJ, Roberts D, Tomkins J, Bushby KM, Shaw PJ. McDermott CJ, et al. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003 Jun;4(2):96-9. doi: 10.1080/14660820310012718. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003. PMID: 14506940

4

Diagnosis and management of motor neurone disease.

McDermott CJ, Shaw PJ. McDermott CJ, et al. BMJ. 2008 Mar 22;336(7645):658-62. doi: 10.1136/bmj.39493.511759.BE. BMJ. 2008. PMID: 18356234 Free PMC article. Review. No abstract available.

5

Chapter 17 Hereditary spastic paraparesis.

McDermott CJ, Shaw PJ. McDermott CJ, et al. Handb Clin Neurol. 2007;82:327-52. doi: 10.1016/S0072-9752(07)80020-0. Handb Clin Neurol. 2007. PMID: 18808902 No abstract available.

6

Physical activity as an exogenous risk factor in motor neuron disease (MND): a review of the evidence.

Harwood CA, McDermott CJ, Shaw PJ. Harwood CA, et al. Among authors: mcdermott cj. Amyotroph Lateral Scler. 2009 Aug;10(4):191-204. doi: 10.1080/17482960802549739. Amyotroph Lateral Scler. 2009. PMID: 19263258 Review.

7

Broad clinical phenotypes associated with TAR-DNA binding protein (TARDBP) mutations in amyotrophic lateral sclerosis.

Kirby J, Goodall EF, Smith W, Highley JR, Masanzu R, Hartley JA, Hibberd R, Hollinger HC, Wharton SB, Morrison KE, Ince PG, McDermott CJ, Shaw PJ. Kirby J, et al. Among authors: mcdermott cj. Neurogenetics. 2010 May;11(2):217-25. doi: 10.1007/s10048-009-0218-9. Epub 2009 Sep 17. Neurogenetics. 2010. PMID: 19760257 Free article.

8

Evaluation of two different methods for per-oral gastrostomy tube placement in patients with motor neuron disease (MND): PIG versus PEG procedures.

Chavada G, El-Nayal A, Lee F, Webber SJ, McAlindon M, Walsh T, Hollinger H, McDermott CJ, Shaw PJ. Chavada G, et al. Among authors: mcdermott cj. Amyotroph Lateral Scler. 2010 Dec;11(6):531-6. doi: 10.3109/17482968.2010.494306. Epub 2010 Jun 16. Amyotroph Lateral Scler. 2010. PMID: 20553092

9

The changing landscape of non-invasive ventilation in amyotrophic lateral sclerosis.

Bourke SC, O'Neill CL, Williams TL, Peel ET, Gibson GJ, McDermott CJ, Shaw PJ. Bourke SC, et al. Among authors: mcdermott cj. J Neurol Neurosurg Psychiatry. 2012 Apr;83(4):368-9. doi: 10.1136/jnnp-2012-302253. J Neurol Neurosurg Psychiatry. 2012. PMID: 22399795 No abstract available.

10

The natural history of motor neuron disease: assessing the impact of specialist care.

Aridegbe T, Kandler R, Walters SJ, Walsh T, Shaw PJ, McDermott CJ. Aridegbe T, et al. Among authors: mcdermott cj. Amyotroph Lateral Scler Frontotemporal Degener. 2013 Jan;14(1):13-9. doi: 10.3109/17482968.2012.690419. Epub 2012 May 29. Amyotroph Lateral Scler Frontotemporal Degener. 2013. PMID: 22642305

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

174 results

Search Page